NCT06268418View on ClinicalTrials.gov

Pre-therapeutic 68Ga-PSMA PET AI Based Dose Prediction for 177Lu-PSMA Targeted Radionuclide Therapy

CompletedOBSERVATIONAL
Enrollment

46

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

June 30, 2025

Conditions
Radionucleide Therapy
Interventions
OTHER

Artificial intelligence

Segmentation

Trial Locations (2)

54511

CHRU de NANCY, Vandœuvre-lès-Nancy

Nuclear medicine Department CHRU de NANCY, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT06268418 - Pre-therapeutic 68Ga-PSMA PET AI Based Dose Prediction for 177Lu-PSMA Targeted Radionuclide Therapy | Biotech Hunter | Biotech Hunter